Treatment of myeloma in patients not eligible for transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-005-0007-0.pdf
Reference66 articles.
1. Jemal A, Tiwari RC, Murray T, et al.: Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8–29.
2. Attal M, Harousseau JL, Stoppa AM, et al.: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996, 335:91–97. A landmark prospective trial comparing autologous bone marrow transplantation with conventional chemotherapy that demonstrates the superiority of transplantation.
3. Child JA, Morgan GJ, Davies FE, et al.: High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003, 348:1875–1883.
4. Crowley J, Fonseca R, Greipp P, et al.: Comparable survival in newly diagnosed multiple myeloma (MM) after VAD induction with high-dose therapy using melphalan 140 mg/m2 + TBI 12 Gy (MEL+TBI) versus standard therapy with VBMCP and no benefit from interferon (IFN) maintenance: Final clinical results of Intergroup Trial S9321 in the context of IFM-90 and Medical Research Council (MRC)-VII trials. Blood 2004, 104:156a-157a.
5. Rajkumar SV, Gertz MA, Kyle RA, et al.: Current therapy for multiple myeloma. Mayo Clin Proc 2002, 77:813–822.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens;Journal of Clinical Oncology;2015-11-20
2. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry;European Journal of Haematology;2012-08-01
3. Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents;Clinical Infectious Diseases;2009-10-15
4. Bench-to-bedside review: Diaphragm muscle function in disuse and acute high-dose corticosteroid treatment;Critical Care;2009
5. Recent major improvement in long-term survival of younger patients with multiple myeloma;Blood;2008-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3